These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29289837)

  • 21. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic silencing of microRNA-218 via EZH2-mediated H3K27 trimethylation is involved in malignant transformation of HBE cells induced by cigarette smoke extract.
    Wang B; Liu Y; Luo F; Xu Y; Qin Y; Lu X; Xu W; Shi L; Liu Q; Xiang Q
    Arch Toxicol; 2016 Feb; 90(2):449-61. PubMed ID: 25526925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Research Progress of Expression and Clinical Significant of EZH2 in Hematological Malignancies--Review].
    Hu JY; Ji YR; Liu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):2097-2012. PubMed ID: 33283749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-101a targeting EZH2 promotes the differentiation of goat skeletal muscle satellite cells.
    Li JT; Zhao W; Li DD; Feng J; Ba G; Song TZ; Zhang HP
    Yi Chuan; 2017 Sep; 39(9):828-836. PubMed ID: 28936980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia.
    Papakonstantinou N; Ntoufa S; Chartomatsidou E; Kotta K; Agathangelidis A; Giassafaki L; Karamanli T; Bele P; Moysiadis T; Baliakas P; Sutton LA; Stavroyianni N; Anagnostopoulos A; Makris AM; Ghia P; Rosenquist R; Stamatopoulos K
    Oncotarget; 2016 Jun; 7(24):35946-35959. PubMed ID: 27191993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors.
    Booth CAG; Barkas N; Neo WH; Boukarabila H; Soilleux EJ; Giotopoulos G; Farnoud N; Giustacchini A; Ashley N; Carrelha J; Jamieson L; Atkinson D; Bouriez-Jones T; Prinjha RK; Milne TA; Teachey DT; Papaemmanuil E; Huntly BJP; Jacobsen SEW; Mead AJ
    Cancer Cell; 2018 Feb; 33(2):274-291.e8. PubMed ID: 29438697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia.
    Chen J; Li J; Han Q; Sun Z; Wang J; Wang S; Zhao RC
    Exp Biol Med (Maywood); 2012 Sep; 237(9):1110-6. PubMed ID: 22956625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target.
    Wen Y; Cai J; Hou Y; Huang Z; Wang Z
    Oncotarget; 2017 Jun; 8(23):37974-37990. PubMed ID: 28415635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Let-7e inhibits TNF-α expression by targeting the methyl transferase EZH2 in DENV2-infected THP-1 cells.
    Zhang Y; Zhang Q; Gui L; Cai Y; Deng X; Li C; Guo Q; He X; Huang J
    J Cell Physiol; 2018 Nov; 233(11):8605-8616. PubMed ID: 29768655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesis.
    Wassef M; Rodilla V; Teissandier A; Zeitouni B; Gruel N; Sadacca B; Irondelle M; Charruel M; Ducos B; Michaud A; Caron M; Marangoni E; Chavrier P; Le Tourneau C; Kamal M; Pasmant E; Vidaud M; Servant N; Reyal F; Meseure D; Vincent-Salomon A; Fre S; Margueron R
    Genes Dev; 2015 Dec; 29(24):2547-62. PubMed ID: 26637281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative proteomic analysis of EZH2 inhibition in acute myeloid leukemia reveals the targets and pathways that precede the induction of cell death.
    Sandow JJ; Infusini G; Holik AZ; Brumatti G; Averink TV; Ekert PG; Webb AI
    Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28447382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of neural stem cells into oligodendrocytes: involvement of the polycomb group protein Ezh2.
    Sher F; Rössler R; Brouwer N; Balasubramaniyan V; Boddeke E; Copray S
    Stem Cells; 2008 Nov; 26(11):2875-83. PubMed ID: 18687996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgens Regulate Ovarian Gene Expression Through Modulation of Ezh2 Expression and Activity.
    Ma X; Hayes E; Biswas A; Seger C; Prizant H; Hammes SR; Sen A
    Endocrinology; 2017 Sep; 158(9):2944-2954. PubMed ID: 28666321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCR/ABL increases EZH2 levels which regulates XIAP expression via miRNA-219 in chronic myeloid leukemia cells.
    Nishioka C; Ikezoe T; Yang J; Yokoyama A
    Leuk Res; 2016 Jun; 45():24-32. PubMed ID: 27070757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
    Tao T; Chen M; Jiang R; Guan H; Huang Y; Su H; Hu Q; Han X; Xiao J
    Oncol Rep; 2017 Mar; 37(3):1430-1436. PubMed ID: 28184935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.
    Erdmann K; Kaulke K; Rieger C; Salomo K; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2249-61. PubMed ID: 27562865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
    Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
    Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic regulation of EZH2 from HPSc to hepatocyte-like cell fate.
    Pistoni M; Helsen N; Vanhove J; Boon R; Xu Z; Ordovas L; Verfaillie CM
    PLoS One; 2017; 12(11):e0186884. PubMed ID: 29091973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
    Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
    J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.